Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) FCF Margin (2024 - 2025)

Beta Bionics (BBNX) has disclosed FCF Margin for 2 consecutive years, with 43.23% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 2937.0% to 43.23% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 56.08% through Dec 2025, up 2326.0% year-over-year, with the annual reading at 56.08% for FY2025, 2326.0% up from the prior year.
  • FCF Margin hit 43.23% in Q4 2025 for Beta Bionics, down from 24.42% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 24.42% in Q3 2025 to a low of 117.21% in Q1 2025.